Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.

Abstract

These data suggest that HIV seropositive IVDUs are not receiving recommended preventive care. Additional efforts will be needed to ensure that HIV-seropositive drug users participate in currently recommended protocols for early treatment of asymptomatic HIV-1 infection.